pharma · Pulmonary Arterial Hypertension · Iron Deficiency Anemia · KROS
Keros Therapeutics
News and analysis for Keros Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Cambridge, USA HQ
2021 Founded
10 Employees
Public company Type
KROS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2021
- Employees
- 10
- Programs
- 3
- Drugs
- 2
- Patents
- 12
News & analysis
NovaPharmaNews articles mentioning Keros Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Keros Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.